M11 may standardize protocol information, but as experts explain here, successful clinical supply execution depends on much more than what’s in the protocol.
- The Bullwhip Effect Hits Clinical Supply Chains
- Does Clinical Development Really Need An S&OP?
- What Your Tier 1 Supplier Map Might Be Missing
- Clinical Trial Supply Chains Need To Prepare For A Less Predictable World
- Root Causes, Part 5: The Structural Changes Clinical Supply Needs
- Rare Disease Trials: Execution Risks No One Warns You About
- Undocumented Changes Break Validated Clinical Systems
- What Happens When The Clinical Forecast Changes?
ON-DEMAND WEBINARS
Learn about strategies that can help build an understanding of risk assessment, in addition to how a study’s protocol requirements, packaging specifications, and more must be identified and addressed.
Explore the opportunities to optimize your supply chain strategy and facilitate direct-to-site, direct-to-patient and hybrid services utilizing a global GMP depot network.
This webinar will offer best practices for UAT for sponsor organizations with the aim of changing the conversations and expectations around the UAT process.
If you are in the process of developing a complex or sensitive injectable drug, learn about containment solutions to mitigate your risks and help you get your drug to the patient faster.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![pharma-success-GettyImages-2217587867]( "Why Advanced cGMP Manufacturing Is Key to Pharma Success")
Why Advanced cGMP Manufacturing Is Key to Pharma SuccessAdvanced cGMP facilities deliver control, expertise, and reliable processes that protect quality and support smooth progress to market. Strong partnerships help reduce risk in complex programs.
-
![BCS2024-1341-05MAY---IQVIA-IRT-Clinical-Trials-Arena-Award-THUMB]( "Streamlining Clinical Supply With Advanced Automation")
Streamlining Clinical Supply With Advanced AutomationClinical trials are the backbone of pharmaceutical advancements, but they come with their own set of challenges, particularly in data management and supply chain logistics.
-
![GettyImages-1293772957-scientist-laboratory-computer-drug-development]( "Five Key Trends In CMC")
Five Key Trends In CMCCMC is evolving with digitalization, sustainability, supply chain resilience, post-merger integration, and personalized medicine.
-
![Digital supply chain mangement, global logistic-GettyImages-2250495598]( "Leveraging A Demand-Led Clinical Supply Model For Program-Level Product Pooling")
Leveraging A Demand-Led Clinical Supply Model For Program-Level Product PoolingSee how a global biopharmaceutical company was able to address inefficiencies and reduce waste within the clinical supply chain for a high-value therapy that faced strong demand but limited supply.
-
![Supply Chain Management GettyImages-1304746031]( "Enhancing Clinical Supply Chain With Signant SmartSignals Supplies")
Enhancing Clinical Supply Chain With Signant SmartSignals SuppliesA global pharma leader improved supply chain efficiency and compliance by digitalizing processes with Signant's SmartSignals Supplies, achieving better visibility, traceability, and reduced errors.
-
![IRT Getty 1407865352]( "How Modern Software Architecture Is Revolutionizing IRT Solutions")
How Modern Software Architecture Is Revolutionizing IRT SolutionsExplore the ways technology suppliers across the clinical trial space have begun investing in IRTs built around a microservices model capable of improving data access and visibility.
-
![West_GCApp_MG (person picking up container)]( "Understanding Injectable Drug Container Closure Systems")
Understanding Injectable Drug Container Closure SystemsChoosing the right container closure system (CCS) format is crucial, so understanding the different parts involved, their functions, storage requirements, and how they impact administering the drug is essential.
-
![clinical-supply-GettyImages-1413600685]( "Building Clinical Supply Agility In A Changing Trial Landscape")
Building Clinical Supply Agility In A Changing Trial LandscapeRising trial complexity demands agile supply built on integrated operations, solid planning, and fast issue resolution. Lean teams gain from partners providing flexibility, control, and global reach.
-
![4_PharmaSource_Conference_CDMO Live copy]( "The Phase 2 Manufacturing Wall: The CMC Risk Hiding In Plain Sight")
The Phase 2 Manufacturing Wall: The CMC Risk Hiding In Plain SightHidden gaps in process maturity and organizational alignment can derail development. Discover how to identify risks early and improve readiness for key milestones.
-
![Risk Management-GettyImages-665231256]( "Flexible Integrations To Reduce Risks And Increase Efficiencies")
Flexible Integrations To Reduce Risks And Increase EfficienciesLearn how a trial team kept the blind of central lab samples and patient treatment across a Phase III and extension trial, whilst optimizing the supply chain.
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.
